Thats why a person with the same BMI as someone else can have a much smoother approval experience if their chart is more complete
Coverage depends on the date, your plan type, and employer decisions: From October 1, 2026: Zepbound returns as a preferred option on standard commercial formularies, covered with standard prior authorization Through September 30, 2026: most commercial plans (Standard, Advanced Control) still exclude Zepbound (excluded July 1, 2025) Self-funded employer plans can override thisyour employer may have kept coverage CVS also removed OSA (sleep apnea) coverage in 2025
The optional Precision Peptide Genetic Test ($298) analyzes genetic variants in peptide-pathway genes including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 to inform personalized dosing and medication selection
You may also enjoy reading our blog on MOTS-c Explained: How This Peptide Supports Energy, Metabolism, and Healthy Aging, which explores one of the most promising mitochondrial peptides in longevity science